Assessment of Health-Related Quality of Life (hrqol) in Triple-Class–exposed Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in the LINKER-MM1 Trial.James E. Hoffman,Naresh Bumma,Joshua Ryan Richter,Madhav V. Dhodapkar,Hans C. Lee,Attaya Suvannasankha,Jeffrey A. Zonder,Joseph J. Maly,Mansi R. Shah,Rachid C. Baz,Michelle DeVeaux,Cristina Ivanescu,Karen Rodriguez-Lorenc,Glenn Scott Kroog,Yariv J. Houvras,Timothy J. Inocencio,Lei Chi,James Harnett,Qiufei Ma,Sundar JagannathJournal of Clinical Oncology（2024）引用 0|浏览22AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
